Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses - Wikidata - awgldk - TriplyDB

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses

http://www.wikidata.org/entity/Q28387782

about

Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine Inﬂuenza and Memory T Cells: How to Awake the Force Coordinated Evolution of Influenza A Surface Proteins Influenza vaccines: a moving interdisciplinary field.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.Virus-vectored influenza virus vaccines.Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Influenza virus antigenicity and broadly neutralizing epitopes.Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015 Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection.Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.Comparison of the Efficacy of N9 Neuraminidase-specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

P2860

Q27342511-DF964BBA-16B8-4762-8F90-3F6A23DF987F Q28070255-77823DBD-8087-4E73-93E3-EFFE42BD3632 Q28547048-5DB38BD0-6FD8-462C-8820-A1C0DA78F916 Q30367695-2852DFA6-0768-4D02-8C70-DB77EF0C39B3 Q30372274-06EA0D49-80E4-4D31-99E7-D9567FE30FFA Q30374446-D6A83D2A-F283-4A20-9024-447BFF76BA6A Q30376724-E59ACD18-AEFE-4171-9785-23424D144B56 Q30380287-0CF602FD-B2B0-4528-BDDA-9655045600A9 Q30386612-E4AE455F-BF11-4BF0-A9B5-82042654A76C Q30386823-A774FF0A-80A3-4AA1-8CAB-8C5FF0F96745 Q30400179-AD37F7A9-AE1D-4810-9E1B-AEA35EDDB206 Q30571702-51320489-82C8-4941-A16E-D8C80BB5BD91 Q33820732-78E04BB0-42D8-4C6F-8CD1-D1A3E6ECFD5D Q34057785-16F85674-610C-46C0-B8E1-802A5C0B43D0 Q34102268-5297A546-E70B-49BA-98E6-646183108693 Q35127236-24939E7C-79EA-4813-9A48-B5659CBD020F Q35139986-EB04DF2E-FD03-4A40-B660-C703BB021BDC Q35214413-B5D3996C-0CA3-4F16-A444-88BC5F5C72BA Q35677624-55D35CC3-B0A6-4A18-96FF-475450F9F38D Q35685270-0CE96B9B-8657-4B92-AC7C-553D973063D1 Q36347157-33B01440-57BE-4673-880B-BA5A392EBCB4 Q37031869-D741CF69-9659-4837-A8F2-905F1F892B01 Q37123064-1922846A-F6E7-4AEA-A04E-1BFB483E996B Q39397313-84B0B156-826C-4CFC-B501-66A171DB1150 Q40049822-4C1C844E-6658-4964-A42B-D7A653BF79E9 Q40075978-D7FD8646-55B4-4FB5-820E-A5AFA8A9E22D Q43673390-5CC6CC86-9D1B-4F7B-93D3-DFD5B557531C Q45324380-9073086B-450D-42BB-BBD5-8A3330C40F63 Q47132783-2CF844C0-3880-4888-82EA-5579C31C8E41 Q47426452-068DC959-A150-4311-9C60-B93D33EA5C34 Q52602393-EDC4D6FB-02CE-4322-B8CC-EAB489EB179C Q52607528-84B896EE-E2DE-4752-A6F2-38CD4FCAE26F Q52609074-DC9CFE47-0B76-4DFF-B3ED-E140121E5601 Q57093905-9541F5DE-28E2-466C-9480-3AE193D75295 Q57094018-BD4BDBC6-D022-461C-B3AC-B3E317884806 Q57299518-B784BF88-ED82-43BC-BE4E-6C3639A15E4A

P2860

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses

http://www.wikidata.org/entity/Q28387782

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@ast

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@en

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@nl

type

label

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@ast

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@en

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@nl

prefLabel

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@ast

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@en

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@nl

P1433

Q28387782-D26CDF1E-5918-4DDC-8B57-F4F612131AC9

P1476

Q28387782-45289C8F-4D10-4AB3-8F7B-ACD29B738946

P2093

Q28387782-005EAE1D-E3E5-4E87-B35B-B1898C517368

Q28387782-07601699-CD67-4614-BE6D-7D0C8D7EC2B9

Q28387782-1EA8C6DB-6D7B-441C-82A7-E0D777A70E1B

Q28387782-23D01538-D337-47A9-8269-8AB2DD24D122

Q28387782-25E67271-3466-4633-9484-06DA403984D6

Q28387782-53336718-081F-4972-AF1E-C7282323D7FF

Q28387782-59B1A043-23EA-410F-88F1-6B0863899E9E

Q28387782-72FBAC30-FE74-4B05-9C30-FADE9AF02004

Q28387782-79DF7093-6D62-4550-8DD9-D4D0A0A0C00D

Q28387782-BA563D12-1CB6-4E6B-9A9F-09A2BB4F7D89

P2860

Q28387782-05ED544A-C945-4E4D-8C99-F1B33EC9DF2E

Q28387782-07AD32F4-15A6-4429-AC31-8587439CED2A

Q28387782-0AB38C50-9A48-4C82-95B2-CA11E4E866ED

Q28387782-0B6A5DB4-F7B3-48E3-8437-31D879961C65

Q28387782-0F62B0A1-8885-456C-B3E3-532D346CE76E

Q28387782-10D523DA-E6F8-4032-8665-4D9292702A5A

Q28387782-11420D69-599B-4049-B587-519CFCF9984E

Q28387782-160D4604-E525-4023-BCDA-C53EB12FD202

Q28387782-16D0F05E-6C46-44C7-8911-2CBA2EC862FA

Q28387782-1A239FE6-6D65-4ACA-BE16-61798053775B

P304

Q28387782-2DAB6D3C-72F8-4EA6-8C93-2F383A75C649

P31

Q28387782-3C2894C5-E522-47B9-AE80-67C7CF713F2F

P3181

Q28387782-24F256CD-4C04-48A7-B36A-282BE33C1B55

P356

Q28387782-72C2B7A1-3E7F-472B-AF92-82378C83D174

P407

Q28387782-37D19015-1C98-4840-AC6C-89CCE3CC7B45

P433

Q28387782-9ED612CE-FCB0-4141-BD55-FD0DE0D68080

P478

Q28387782-76352B7C-3961-4C3F-8D5D-ED08FBBBB020

P50

Q28387782-202CE72E-5A04-404E-BF10-A0642CED54CD

Q28387782-EAFA4C3C-2FF2-4C7D-8AED-64F3CF2CEF33

Q28387782-FF812B72-7C96-4D33-B8BD-EB9E942E4CA7

P577

Q28387782-6B9BD91A-218F-4E62-B583-0834F6E5CEFE

P5875

Q28387782-BF6218C0-6E1A-4E42-8D45-DDCEEC3EDA5E

P698

Q28387782-5BEBF17A-10C6-470F-B305-018A08F91C1F

P921

Q28387782-850A5BFE-4C72-4D62-BFAA-EFD90553A6CD

P932

Q28387782-4FF08577-A6F6-4B02-8077-BAABCFD851DB

P3181

P356

P1433

Journal of Virology

P1476

Molecular basis for broad neur ...... well as H5N1 influenza viruses

@en

P2093

Hongjun Chen

http://www.w3.org/2001/XMLSchema#string

Hongquan Wan

http://www.w3.org/2001/XMLSchema#string

Ishrat Sultana

http://www.w3.org/2001/XMLSchema#string

Jianqiang Ye

http://www.w3.org/2001/XMLSchema#string

Jin Gao

http://www.w3.org/2001/XMLSchema#string

Judy D Easterbrook

http://www.w3.org/2001/XMLSchema#string

Katie H Rivers

http://www.w3.org/2001/XMLSchema#string

Kemin Xu

http://www.w3.org/2001/XMLSchema#string

Kevin Yang

http://www.w3.org/2001/XMLSchema#string

Laura K Couzens

http://www.w3.org/2001/XMLSchema#string

P2860

Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus

Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus

Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

P304

9290-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2227112

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01203-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Jeffery Taubenberger

Daniel R. Perez

Maryna C Eichelberger

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240306824

http://www.w3.org/2001/XMLSchema#string

P698

23785204

http://www.w3.org/2001/XMLSchema#string

P921

P932

3754050

http://www.w3.org/2001/XMLSchema#string